EVOKE WEALTH, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
EVOKE WEALTH, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$2,0000.0%4680.0%0.00%
Q3 2021$2,000
-33.3%
4680.0%0.00%
Q2 2021$3,0000.0%4680.0%0.00%
Q1 2021$3,0000.0%4680.0%0.00%
Q4 2020$3,0000.0%4680.0%0.00%
Q3 2020$3,000
+50.0%
4680.0%0.00%
Q2 2020$2,0004680.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,138,872$40,639,00022.88%
Abingworth LLP 1,301,413$24,701,00014.43%
Roumell Asset Management, LLC 201,845$3,835,0007.78%
GREAT POINT PARTNERS LLC 453,878$8,624,0003.41%
Aisling Capital LLC 682,680$12,971,0002.28%
Broadfin Capital, LLC 530,283$10,075,0000.56%
Tekla Capital Management LLC 762,581$14,489,0000.52%
Baupost Group 1,544,498$29,345,0000.49%
GENERAL AMERICAN INVESTORS CO INC 277,076$5,264,0000.47%
Lombard Odier Asset Management (USA) Corp 135,710$2,578,0000.22%
View complete list of PARATEK PHARMACEUTICALS INC shareholders